Review: taking Warfarin sodium and Flurbiprofen together


Summary

Drug interactions are reported among people who take Warfarin sodium and Flurbiprofen together. This review analyzes the effectiveness and drug interactions between Warfarin sodium and Flurbiprofen. It is created by eHealthMe based on reports of 18 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Warfarin sodium and Flurbiprofen >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Warfarin Sodium

Warfarin sodium has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Warfarin sodium 48,044 users)

Flurbiprofen

Flurbiprofen has active ingredients of flurbiprofen. It is often used in rheumatoid arthritis. (latest outcomes from Flurbiprofen 1,238 users)

On Jul, 24, 2016

18 people who take Warfarin Sodium, Flurbiprofen are studied.


Number of reports submitted per year:

Warfarin sodium and Flurbiprofen drug interactions.

Drug effectiveness over time:

Warfarin Sodium:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Flurbiprofen:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Warfarin Sodium:
  • female: 0.0% - (0 of 0 people)
  • male: 100.0% - (1 of 1 people)
Flurbiprofen:
  • female: 0.0% - (0 of 0 people)
  • male: 0.0% - (0 of 1 people)

Drug effectiveness by age:

Warfarin Sodium:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 100.0% - (1 of 1 people)
Flurbiprofen:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • decreased appetite
  • deep vein thrombosis
  • cholecystitis acute
  • liver disorder
  • malaise
  • oedema peripheral
  • pancytopenia
  • pulmonary artery thrombosis
  • renal impairment
  • upper respiratory tract infection
1 - 6 months:
  • oedema peripheral
  • pancytopenia
  • renal impairment
  • upper respiratory tract infection
  • decreased appetite
  • deep vein thrombosis
  • liver disorder
6 - 12 months:
  • dermatitis exfoliative
  • dry skin
  • pruritus
1 - 2 years:
  • haematoma
  • haemoglobin decreased
  • international normalised ratio increased
  • pain in extremity
not specified:
  • pulmonary embolism
  • dyspnoea exertional
  • pain
  • deep vein thrombosis
  • pain in extremity
  • muscle spasms
  • swelling
  • tachycardia
  • cardiac failure
  • congestive cardiomyopathy

Most common drug interactions by gender *:

female:
  • pulmonary embolism
  • deep vein thrombosis
  • pain
  • dyspnoea exertional
  • muscle spasms
  • pain in extremity
  • swelling
  • homans' sign
  • oedema peripheral
  • pruritus
male:
  • cardiac failure
  • congestive cardiomyopathy
  • ejection fraction decreased
  • hypotension
  • intracardiac thrombus
  • mitral valve incompetence
  • multiple injuries
  • pulmonary hypertension
  • surgery
  • tachycardia

Most common drug interactions by age *:

20-29:
  • histiocytosis haematophagic
  • pneumonia cytomegaloviral
  • white blood cell count decreased
40-49:
  • deep vein thrombosis
  • dyspnoea exertional
  • muscle spasms
  • pain
  • pain in extremity
  • pulmonary embolism
  • swelling
  • homans' sign
  • oedema peripheral
  • altered state of consciousness
50-59:
  • cardiac failure
  • congestive cardiomyopathy
  • ejection fraction decreased
  • hypotension
  • intracardiac thrombus
  • mitral valve incompetence
  • multiple injuries
  • pulmonary hypertension
  • surgery
  • tachycardia
60+:
  • drug eruption
  • eczema
  • excoriation
  • eye disorder
  • inflammation
  • pruritus
  • sepsis
  • back pain
  • calcinosis
  • pancytopenia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Warfarin sodium and Flurbiprofen?

Can you answer these questions?

More questions for: Warfarin sodium, Flurbiprofen

You may be interested in these reviews

More reviews for: Warfarin sodium, Flurbiprofen

On eHealthMe, Warfarin sodium (warfarin sodium) is often used to treat atrial fibrillation/flutter. Flurbiprofen (flurbiprofen) is often used to treat rheumatoid arthritis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.